Olanzapine/fluoxetine combination in patients with treatment-resistant depression / Mauricio Tohen en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 4 (Abril)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 4 (Abril) . - pp. 451-462 Título : Olanzapine/fluoxetine combination in patients with treatment-resistant depression : rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies Tipo de documento: texto impreso Autores: Mauricio Tohen, Autor ; Michael Case, Autor ; Madhukar H. Trivedi, Autor Fecha de publicación: 2022 Artículo en la página: pp. 451-462 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Benzodiazepinas, Trastorno depresivo, Aprobación de medicamentos, Farmacoterapia, Fluoxetina, Olanzapina, Índice de gravedad de la enfermedad. Resumen: To characterize response profiles of olanzapine/fluoxetine combination therapy in treatment-resistant depression (TRD) and to investigate predictive relationships of early improvement with olanzapine/fluoxetine combination for subsequent response/remission during the acute phase of treatment. Link: ./index.php?lvl=notice_display&id=28173 [artículo] Olanzapine/fluoxetine combination in patients with treatment-resistant depression : rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies [texto impreso] / Mauricio Tohen, Autor ; Michael Case, Autor ; Madhukar H. Trivedi, Autor . - 2022 . - pp. 451-462. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 4 (Abril) . - pp. 451-462 Palabras clave: Benzodiazepinas, Trastorno depresivo, Aprobación de medicamentos, Farmacoterapia, Fluoxetina, Olanzapina, Índice de gravedad de la enfermedad. Resumen: To characterize response profiles of olanzapine/fluoxetine combination therapy in treatment-resistant depression (TRD) and to investigate predictive relationships of early improvement with olanzapine/fluoxetine combination for subsequent response/remission during the acute phase of treatment. Link: ./index.php?lvl=notice_display&id=28173

Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder / Vicki P Hoffmann en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 6 (Diciembre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 656-660 Título : Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder : post hoc analyses of 3 randomized, controlled clinical trials Tipo de documento: texto impreso Autores: Vicki P Hoffmann, Autor ; Michael Case, Autor ; Virginia L. Stauffer, Autor Fecha de publicación: 2022 Artículo en la página: pp. 656-660 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Glucosa, Peso, Triglicéridos, Antipsicóticos Resumen: The objective of this study was to determine if early changes in triglycerides and weight may be useful in predicting longer-term changes in weight and other metabolic parameters. Data were from three 24- to 28-week randomized, controlled studies comparing olanzapine to ziprasidone or aripiprazole for treatment of schizophrenia. Link: ./index.php?lvl=notice_display&id=29411 [artículo] Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder : post hoc analyses of 3 randomized, controlled clinical trials [texto impreso] / Vicki P Hoffmann, Autor ; Michael Case, Autor ; Virginia L. Stauffer, Autor . - 2022 . - pp. 656-660. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 656-660 Palabras clave: Glucosa, Peso, Triglicéridos, Antipsicóticos Resumen: The objective of this study was to determine if early changes in triglycerides and weight may be useful in predicting longer-term changes in weight and other metabolic parameters. Data were from three 24- to 28-week randomized, controlled studies comparing olanzapine to ziprasidone or aripiprazole for treatment of schizophrenia. Link: ./index.php?lvl=notice_display&id=29411

---

1 (1 - 2 / 2)